Skip to main content

Isabella Bank Institute for Entrepreneurship

We are a dedicated institute for student entrepreneurs across campus and beyond. We aim to maximize your success by fostering your entrepreneurial mindset, promote inter-disciplinary collaboration and provide support for the creation and development of your new ventures. Jumpstart your ideas and get involved today!

Tune in for excitement!

Passion. Potential. Pitches. Don't miss any of the 2025 New Venture Challenge excitement.

Tune in Friday, April 11 at 1 p.m. for great ideas and fierce competition. Then, join the judges, mentors, spectators and teams as they see who is going home with thousands of dollars in venture financing. The awards broadcast begins at 6:30 p.m. and one team will walk away as the overall best venture. 

Start your entrepreneurial journey

Central Michigan University’s College of Business Administration is the home of the Isabella Bank Institute for Entrepreneurship and the first Department of Entrepreneurship in the state of Michigan. We are a student-centric hub where experiential, curricular, and external entrepreneurial opportunities intersect.

Our mission is to maximize student success by fostering a campus-wide entrepreneurial mindset that promotes inter-disciplinary collaboration and the creation of new ventures.

We aim to create innovative programming, boost cross-campus and ecosystem collaboration and provide a comprehensive mentoring program.

Our institute provides extracurricular opportunities and is open to all undergraduate and graduate CMU students.

Student opportunities

  • Meet experienced alumni, faculty, entrepreneurs, investors, and other business and political leaders.
  • Learn practical skills, innovative thinking, and connect with mentors and entrepreneurial resources.
  • Attend skill-building workshops and compete in pitch competitions and Hackathons.
  • Take part in special scholarship programs and travel experiences.
  • Pitch your venture at our signature New Venture Challenge event and compete for up to $20,000 in cash awards.

      Find your path

      Are you interested in becoming an entrepreneur?

      Every journey is unique. Explore the opportunities that interest you.

      Parkinson’s research highlighted at international conference

      by Teagan Haynes

      Tommie Cammarano, a second-year Neuroscience Ph.D. student at CMU, recently attended the Grand Challenges in Parkinson’s Disease Conference at the Van Andel Research Institute, originally expecting to be an audience member. However, her plans took a surprising turn when she found out she would be presenting her own work. Originally drawn to the conference by a highly recognized keynote speaker, Cammarano’s advisor, Michael Sandstrom, Ph.D. encouraged her to submit a poster on her Parkinson’s disease research. Out of 40 abstract submissions, only two were selected to deliver talks, one of them being hers.  

      Cammarano’s talk described her current study which investigates the combination of exercise and light-activated stem cell transplantation as a potential treatment for Parkinson's disease. This innovative approach using the rat, which is a common research model, allows transplanted stem cells to be stimulated by light, enhancing their integration into the brain when paired with exercise. 

      Cammarano’s long-term rat study extends over two months, which is the equivalent of several years in humans. In Cammarano’s model, Parkinson’s disease is induced in one side of the brain in the rats, and stem cells are then transplanted into that same side of their brain. The rats undergo regular exercise over the course of two months to evaluate the effects of the stem cells and exercise on levels of dopamine and their recovery. At the end of the study, Cammarano will measure dopamine levels in the previously injured side of the brain, during both rest and active exercise. Since Parkinson’s symptoms are caused by the loss of dopamine, an important chemical in nerve cells, Cammarano aims to see if the treatment increases dopamine levels.  

      Cammarano found presenting her research to a crowd of 150 professionals to be somewhat intimidating, but it was also incredibly rewarding to gain valuable feedback from experts in the field. Cammarano hopes her research will one day contribute to effective treatments for Parkinson's disease, expanding the scope of available therapies for neurodegenerative diseases. 

      Questions?